Timing hormonal therapy in prostate cancer.

Annette E Sessions, Edward M Messing

Journal: The Urologic clinics of North America 2002;29(1):223-7, xi

PMID: 12109348

Full Text on Elsevier Science View on PubMed

Abstract

The history of the use of hormonal therapy to treat prostrate cancer is outlined, focusing on such treatments and disease scenarios as diethylstilboestrol therapy, androgen ablation alone or in conjunction with radiation, and the treatment of minimal disease burdens. Studies have pointed to the benefits of initiating androgen ablation therapy earlier in the treatment of prostate cancer; the greatest benefits of anti-androgen therapy may be gained when only tiny amounts of prostate cancer are present.

Address: Department of Urology, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, NY 14642, USA.

DOI: 10.1016/s0094-0143(02)00007-1

Link outs

Free resources

Medical:

https://medlineplus.gov/prostatecancer.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Antineoplastic Agents, Hormonal, Clinical Trials as Topic, Combined Modality Therapy, Diethylstilbestrol, Drug Administration Schedule, Humans, Male, Prostatic Neoplasms